IRIDEX Corporation today announced commercial availability of a new family of Adjustable & Intuitive EndoProbe laser handpieces for use with the Company’s laser platforms in vitreoretinal surgery. The Adjustable & Intuitive Laser Probes speed up treatm…
Uncategorized
Certain new therapies for age-related eye disease do not appear to increase heart risks
Newer treatments for age-related macular degeneration — including an intravitreous (into the eye) injection of a chemotherapy drug and use of a related compound approved for use against the eye disease — do not appear to be associated with an increas…
Uncategorized
Treatment of retinal conditions appears to have changed significantly in previous decade
The number of Medicare recipients undergoing treatment for retinal conditions nearly doubled between 1997 and 2007, with significant shifts in the types of procedures most commonly performed, according to a new report.
IRIDEX Announces Commercial Availability Of New Adjustable & Intuitive EndoProbe® Device For Eye Surgery
IRIDEX Corporation today announced commercial availability of a new family of Adjustable & Intuitive EndoProbe laser handpieces for use with the Company’s laser platforms in vitreoretinal surgery. The Adjustable & Intuitive Laser Probes speed up treatm…
Alcon Introduces New Systane(R) BALANCE Lubricant Eye Drops For Dry Eye Patients With Meibomian Gland Dysfunction
Alcon, Inc. (NYSE: ACL), the world’s leader in eye care, announced the launch of Systane(R) BALANCE Lubricant Eye Drops, the newest lubricant eye drop in the Systane(R) family of products. Patients with Meibomian Gland Dysfunction (MGD) are unable to a…
Anti-VEGF Therapy Produces Significant Reduction In Anatomical Measures Of CNV
Treatment of neovascular age-related macular degeneration with anti-VEGF therapy leads to rapid reduction of lesion size that is evident on optical coherence tomography.